RE:RE:RE:RE:RE:BLAObviously they will have to come up with money one way or another before the BLA unless they get the BLA very fast.
And they are not gonna wait until there is no more cash available unless Thomvest wants another restructuration in order to wipe again the shareholders and Consonnance.
With the resubmission being accepted by the FDA, it brings more credibility and should help get financing.
Also, the new PDUFA date of 5 march 2021 is not the day they will get the BLA.
It is the latter they will get it.
Since this is a resubmission, a large part of the original BLA, 4 of 5 modules are already reviewed.
And CMC module was also reviewed.
So basically, FDA has to review the modification in the CMC module with the 4 new check points.
So the normal 6 months period for the 5 modules should be much shorter as in many other past cases (from other BLA resubmission from other pharma for other drugs) since it is not a complete review of the BLA
Once/if they get the BLA, and I believe they will, everything is going to change since revenu will start coming in as well as credibility.
IMHO